Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05127174
Title Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

polycythemia vera

myeloproliferative neoplasm

myelofibrosis

Therapies

Fedratinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.